Viral inhibitors

Thiourea compounds have been observed to inhibit human immunodeficiency virus (HIV) reverse transcriptase, a viral enzyme that is responsible for the reverse transcription of the retroviral RNA to proviral DNA. Phenethylthiazoylthiourea (PETT) compounds were discovered as potent inhibitors of HIV type 1 and display certain structure-activity relationships among various substituents in their structure.199 207 Furthermore, thiourea derivatives have been found to be potent and selective viral inhibitors, antifungal and antibacterial compounds.208 215... 

Marine sponges contain a host of bioactive compounds, particularly small molecules, and also contain a range of peptides that are non-ribosomally synthesised, often containing non-native amino acids. However, there are examples of peptides of ribosomal origin, including, for example, asteropine A isolated from the sponge Asteropus simplex.133 This peptide comprises 36 residues and three disulphide bonds. It has potent sialidase inhibitory activity and thus has applications in the design of novel viral inhibitors. Structural analysis of asteropine A with NMR spectroscopy revealed a cystine-knot motif, similar to that already described for plant toxins. This observation emphasises the fact that the cystine-knot motif is extremely prevalent in disulphide-rich peptides.134 Asteropine A, discovered in 2006, was the first reported cystine-knot peptide isolated from marine invertebrates other than from cone snails, which are described in more detail below. 

Lockart Jr., R. Z. (1973). In Interferons and Interferon Inducers (ed N. B. Finter), Criteria for acceptance of a viral inhibitor as an interferon and a general description of the biological properties of known interferons, pp. 11-27. North-Holland Publishing, Amsterdam. 

Viral Inhibitors. A multivalency approach was used to inhibit influenza virus in-fectivity. Several sialic acid-based polymers have been synthesized that inhibit flu virus receptor-binding activity, which in turn impedes flu viruses from sticking to cell surfaces and subsequent viral infection of cells (see also Section 2.1.4) (155,156). 

HIV is also good at evading the innate immunity system. Natural killer cells attempt to attack the virus, but HIV binds a particular cell protein, called cyclophilin, to its capsid, which blocks the antiviral agent known as restriction factor-1. Another of HIV s proteins blocks the viral inhibitor called CEM-15, which normally disrupts the viral life cycle. 

Detecting the effectiveness of the candidate compound as a viral inhibitor without inducing a viral resistance. 

It is likely that other unique viral inhibitors of TAP will be defined, including early proteins derived from bovine herpes virus BHVl (Hinkley et al. 1998) and pseudorabies virus (Ambagala et al. 2000). These will not only result in recognition of the strategies viruses use to hide for the immune system but will also provide a flow of information on the mechanism of action of the peptide transporter TAP. 

Fig. 1. Modulation of apoptosis by v-FLIP and v-Bcl-2. v-FLIPs specifically inhibit apoptosis mediated by death receptors. v-lCA specifically targets caspase-8 and inhibits its activation. v-Bcl-2 and vMIA inhibit those apoptotic pathways that are signaled through mitochondrial release of cytochrome c. FADD, Fas-associated death domain FLICE, FADD-like interleukin-converting enzyme CARD, cas-pase-recruiting domain PTPC. permeability transition pore complex FLIP, FLICE-inhibitory protein vie A, viral inhibitor of caspase 8-induced-apoptosis MIA. viral mitochondrial inhibitor of apoptosis Apcif-l, apoptotic protease-activating factor 1...

The ideal candidate for a virus-derived anti-TNF therapeutic would be more specific and less toxic to the human system than current therapies. Several viral inhibitors can specifically block intracellular s naling, often resulting in reduced TNF production or its TNFR-dependant effects. Activation of NF-kB is an early event that occurs within minutes after exposure to TNF and plays important role in inflammation, regulation of cell proliferation, activation and survival. This activation process has turned out to be an attractive target for viruses to escape immune defenses and many viruses have evolved specific gene products to inhibit the TNF-induced NF-kB activation. 

F and C regions are translated with equal frequency (IO). This result, obtained on normally fimctioning virus in the absence of viral inhibitors or analogs, not only supported the idea of a single initiation site but also implied the operation of only one termination site, thus... 

The purpose of these experiments was to determine whether primary transcription from the 3 end of the VSV genome was essential to express its capacity to inhibit cellular RNA synthesis. Quite obviously, such studies could not distinguish between viral RNAs and proteins as the potential inhibitors. The use of protein synthesis inhibitors, such as cycloheximide, puromycin, and amino acid analogues, always resulted in inhibition of cellular RNA synthesis as well (Week and Wagner, unpublished data), thus, precluding this approach to the problem of identifying the viral inhibitor. 

The complex formation of polycations with RNA, analyzed by the membrane filter technique in association with the assay of viral RNA infectivity, can be used to study the influence of biologically active substances like carcinogens, viral inhibitors, or heavy metal ions on nucleic acid-protein interaction. 

---